134 related articles for article (PubMed ID: 37737883)
1. Effects of matcha tea extract on cell viability and estrogen receptor-β expression on MCF-7 breast cancer cells.
Keckstein S; Tilgener C; Jeschke U; Hofmann S; Vilsmaier T; Keilmann L; Heidegger H; Kaltofen T; Batz F; Mahner S; Schröder L
Arch Gynecol Obstet; 2024 Apr; 309(4):1509-1514. PubMed ID: 37737883
[TBL] [Abstract][Full Text] [Related]
2. Effects of matcha tea extract on cell viability and peroxisome proliferator-activated receptor γ expression on T47D breast cancer cells.
Keckstein S; Tilgener C; Jeschke U; Hofmann S; Vilsmaier T; Kaltofen T; Heidegger H; Batz F; Mahner S; Schröder L
Arch Gynecol Obstet; 2022 Aug; 306(2):451-459. PubMed ID: 35079875
[TBL] [Abstract][Full Text] [Related]
3. The presence of Estrogen Receptor β modulates the response of breast cancer cells to therapeutic agents.
Pons DG; Torrens-Mas M; Nadal-Serrano M; Sastre-Serra J; Roca P; Oliver J
Int J Biochem Cell Biol; 2015 Sep; 66():85-94. PubMed ID: 26232188
[TBL] [Abstract][Full Text] [Related]
4. The effect of hesperetin on estrogen receptor gene expression and its relationship with the downstream pathways of estrogen receptor alpha.
Bideh M; Safari S; Khedri A; Zangooei M
Mol Biol Rep; 2023 Sep; 50(9):7225-7236. PubMed ID: 37418087
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
Treeck O; Lattrich C; Springwald A; Ortmann O
Breast Cancer Res Treat; 2010 Apr; 120(3):557-65. PubMed ID: 19434490
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivity.
Lindberg K; Helguero LA; Omoto Y; Gustafsson JÅ; Haldosén LA
Breast Cancer Res; 2011 Apr; 13(2):R43. PubMed ID: 21492444
[TBL] [Abstract][Full Text] [Related]
7. Effects of green tea, matcha tea and their components epigallocatechin gallate and quercetin on MCF‑7 and MDA-MB-231 breast carcinoma cells.
Schröder L; Marahrens P; Koch JG; Heidegger H; Vilsmeier T; Phan-Brehm T; Hofmann S; Mahner S; Jeschke U; Richter DU
Oncol Rep; 2019 Jan; 41(1):387-396. PubMed ID: 30320348
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor β inhibits breast cancer cells migration and invasion through CLDN6-mediated autophagy.
Song P; Li Y; Dong Y; Liang Y; Qu H; Qi D; Lu Y; Jin X; Guo Y; Jia Y; Wang X; Xu W; Quan C
J Exp Clin Cancer Res; 2019 Aug; 38(1):354. PubMed ID: 31412908
[TBL] [Abstract][Full Text] [Related]
9. Effects of ICI 182,780, an ERα and ERβ antagonist, and G-1, a GPER agonist, on autophagy in breast cancer cells.
Muler ML; Antunes F; Guarache GC; Oliveira RB; Ureshino RP; Bincoletto C; Pereira GJDS; Smaili SS
Einstein (Sao Paulo); 2020; 18():eAO4560. PubMed ID: 32321078
[TBL] [Abstract][Full Text] [Related]
10. Nutraceuticals known to promote hair growth do not interfere with the inhibitory action of tamoxifen in MCF7, T47D and BT483 breast cancer cell lines.
Baker R; Dell'Acqua G; Richards A; Thornton MJ
PLoS One; 2024; 19(2):e0297080. PubMed ID: 38408073
[TBL] [Abstract][Full Text] [Related]
11. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells.
Chang EC; Frasor J; Komm B; Katzenellenbogen BS
Endocrinology; 2006 Oct; 147(10):4831-42. PubMed ID: 16809442
[TBL] [Abstract][Full Text] [Related]
12. Genistein modulates oxidative stress in breast cancer cell lines according to ERα/ERβ ratio: effects on mitochondrial functionality, sirtuins, uncoupling protein 2 and antioxidant enzymes.
Nadal-Serrano M; Pons DG; Sastre-Serra J; Blanquer-Rosselló Mdel M; Roca P; Oliver J
Int J Biochem Cell Biol; 2013 Sep; 45(9):2045-51. PubMed ID: 23871935
[TBL] [Abstract][Full Text] [Related]
13. The Phytoestrogen Genistein Affects Breast Cancer Cells Treatment Depending on the ERα/ERβ Ratio.
Pons DG; Nadal-Serrano M; Torrens-Mas M; Oliver J; Roca P
J Cell Biochem; 2016 Jan; 117(1):218-29. PubMed ID: 26100284
[TBL] [Abstract][Full Text] [Related]
14. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
[TBL] [Abstract][Full Text] [Related]
15. The phytoestrogen genistein affects inflammatory-related genes expression depending on the ERα/ERβ ratio in breast cancer cells.
Pons DG; Vilanova-Llompart J; Gaya-Bover A; Alorda-Clara M; Oliver J; Roca P; Sastre-Serra J
Int J Food Sci Nutr; 2019 Dec; 70(8):941-949. PubMed ID: 30945577
[TBL] [Abstract][Full Text] [Related]
16. Obesity Suppresses Estrogen Receptor Beta Expression in Breast Cancer Cells via a HER2-Mediated Pathway.
Bowers LW; Wiese M; Brenner AJ; Rossi EL; Tekmal RR; Hursting SD; deGraffenried LA
PLoS One; 2015; 10(12):e0145452. PubMed ID: 26709918
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of PTEN decreases expression of estrogen receptor β and tamoxifen sensitivity of human breast cancer cells.
Treeck O; Schüler-Toprak S; Skrzypczak M; Weber F; Ortmann O
Steroids; 2020 Jan; 153():108521. PubMed ID: 31604073
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor beta-mediated proliferative inhibition and apoptosis in human breast cancer by calycosin and formononetin.
Chen J; Zhao X; Ye Y; Wang Y; Tian J
Cell Physiol Biochem; 2013; 32(6):1790-7. PubMed ID: 24355881
[TBL] [Abstract][Full Text] [Related]
19. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.
Li HJ; Wang LY; Qu HN; Yu LH; Burnstock G; Ni X; Xu M; Ma B
Mol Cell Endocrinol; 2011 May; 338(1-2):28-37. PubMed ID: 21356271
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor β selective agonists reduce invasiveness of triple-negative breast cancer cells.
Hinsche O; Girgert R; Emons G; Gründker C
Int J Oncol; 2015 Feb; 46(2):878-84. PubMed ID: 25420519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
